News from mimedx group, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 30, 2014, 07:30 ET

MiMedx Achieves Record Revenue And Records First Operating Profit

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Oct 21, 2014, 12:07 ET

MiMedx Provides Update On Outstanding Patent Litigation

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Oct 16, 2014, 10:07 ET

MiMedx At Fall 2014 SAWC: Studies And Key Opinion Leaders Present Clinical Evidence Of EpiFix Healing Results On Chronic And Acute Wounds

MiMedx Group, Inc. (NASDAQ: MDXG) EpiFix® dehydrated human amnion/chorion membrane (dHACM) allografts have been shown to be clinically...

Oct 13, 2014, 07:30 ET

MiMedx Third Quarter Revenue Of $33.5 Million Exceeds Upper End Of Guidance

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Oct 06, 2014, 16:29 ET

MiMedx Announces Release Date for 2014 Third Quarter Results

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Sep 30, 2014, 16:08 ET

MiMedx to Present at the Stem Cell Meeting on the Mesa

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Sep 24, 2014, 09:22 ET

Study Determines MiMedx Allograft Effectively Recruits Circulating Stem and Progenitor Cells

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Sep 17, 2014, 13:40 ET

MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Sep 08, 2014, 16:49 ET

MiMedx To Webcast Its Analyst Day On October 14th

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer  of  patent  protected...

Sep 03, 2014, 09:34 ET

Fifth MiMedx Scientific Study Published In Peer-Reviewed Journal

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Aug 04, 2014, 13:33 ET

MiMedx To Present At 34th Annual Canaccord|Genuity Growth Conference

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Jul 28, 2014, 23:00 ET

MiMedx Announces Record Second Quarter Results

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Jul 23, 2014, 07:59 ET

MiMedx Files Its Initial Investigational New Drug Application

 MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, processor and marketer of patent-protected regenerative biomaterials and...

Jul 22, 2014, 16:51 ET

Restrospective Analysis Finds MiMedx EpiFix® As Most Effective In Rapid Resolution Of Diabetic Foot Ulcers When Compared With Two Other Skin Substitutes

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Jul 15, 2014, 08:42 ET

MiMedx Announces Release Date For 2014 Second Quarter Results

MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants...

Jul 14, 2014, 10:47 ET

MiMedx Announces Revised Local Coverage Determination From Medicare Contractor That Includes EpiFix®

MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants...

Jun 19, 2014, 11:15 ET

MiMedx Expects To File Its First Investigational New Drug Application In July

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent-protected regenerative biomaterials and...

Jun 19, 2014, 10:45 ET

MiMedx Increases Guidance For Second Quarter And Full Year 2014

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent-protected regenerative biomaterials and...

Jun 04, 2014, 10:02 ET

MiMedx Board Applauds Dismissal Of Lawsuit Against Chairman & CEO

 The Board of Directors of MiMedx Group, Inc. (NASDAQ: MDXG), announced today that the Board applauds the dismissal of the lawsuit brought...

May 27, 2014, 17:15 ET

MiMedx Increases Lower End Of Guidance For Second Quarter And Full Year 2014

 MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, processor and marketer of patent-protected regenerative biomaterials and...